中文 | English
Return
Total: 5583 , 1/559
Show Home Prev Next End page: GO
Author:( Shu Wang)

1.Anti-thyroid drugs—first choice for Graves' disease

Shu WANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry

Shuling WANG ; Shu WANG

China Pharmacy 2005;0(16):-

3.Endovascular repair for retrograde type A aortic dissection with an entry tear in the descending aorta

Chang SHU ; Tun WANG

Chinese Journal of General Surgery 2013;28(12):911-914

4.Toll-like receptors and bacterial infection

Shu ZHANG ; Huiqin WANG

International Journal of Pediatrics 2014;(5):523-526

6.Discussion on Customer Value Management in Pharmaceutical Enterprises

Shu WANG ; Yuwen CHEN

China Pharmacy 1991;0(04):-

7.CSI:New Factor for Marketing Competition of Pharmaceutical Enterprises

Shu WANG ; Wenzhan YANG

China Pharmacy 1991;0(01):-

8.Thinking About the Packaging of Pharmaceutical Products and the Safety of Drug Use

Wenzhan YANG ; Shu WANG

China Pharmacy 1991;0(06):-

9.Current advance in genetics and clinical phenotype of Leber congenital amaurosis

Shu-ran, WANG

Chinese Journal of Experimental Ophthalmology 2013;31(12):1178-1182

10.Analysis of Clinical and Pathological Characteristics and Prognosis in 21 Children with Primary Focal Segmental Glomerulosclerosis

shu, TENG ; mo, WANG

Journal of Applied Clinical Pediatrics 1992;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5583 , 1/559 Show Home Prev Next End page: GO